Home       Privacy       Archive       Realtime Report



Stock Trading History of Fhm V, Llc

The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Fhm V, Llc since year 2005. The trader's CIK number is 1346944. At the time of this reporting, Fhm V, Llc is the 10% Owner of Amicus Therapeutics Inc (stock ticker symbol FOLD).

Stock purchases, sales, and option exercises reported by insider Fhm V, Llc since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2008-02-04 FOLD Amicus Therapeutics Inc Purchase 25,352 10.15 257,348
2008-02-04 FOLD Amicus Therapeutics Inc Purchase 33,823 10.41 352,218
2008-02-05 FOLD Amicus Therapeutics Inc Purchase 35,536 10.24 363,710
2008-02-05 FOLD Amicus Therapeutics Inc Purchase 32,864 10.42 342,365
2008-02-01 FOLD Amicus Therapeutics Inc Purchase 32,100 9.26 297,149
2008-02-01 FOLD Amicus Therapeutics Inc Purchase 28,700 9.60 275,376
2008-02-01 FOLD Amicus Therapeutics Inc Purchase 13,600 9.82 133,531
2008-01-31 FOLD Amicus Therapeutics Inc Purchase 6,215 9.60 59,693
2008-02-01 FOLD Amicus Therapeutics Inc Purchase 5,600 9.04 50,652
2008-01-31 FOLD Amicus Therapeutics Inc Purchase 8,800 10.34 91,011
2007-08-08 FOLD Amicus Therapeutics Inc Purchase 29,600 11.50 340,400
2007-07-27 FOLD Amicus Therapeutics Inc Purchase 17,800 11.37 202,341
2007-07-25 FOLD Amicus Therapeutics Inc Purchase 29,700 11.42 339,176
2007-07-26 FOLD Amicus Therapeutics Inc Purchase 3,896 11.30 44,033
2007-07-26 FOLD Amicus Therapeutics Inc Purchase 4,104 11.47 47,083

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Fhm V, Llc (10% Owner of Amicus Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

© 2005-2008, insider-monitor.com. All rights reserved.